To meet the medical need of pets, we develop species-specific therapeutic antibodies from our own platform
Location: Germany, Bavaria, Planegg
Total raised: $2.46M
Investors 2
| Date | Name | Website |
| - | OCCIDENT | occident.g... |
| - | High-Tech ... | htgf.de |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 18.10.2022 | - | $2.46M | - |
Mentions in press and media 5
| Date | Title | Description | Source |
| 15.09.2023 | Veterinary pharmaceuticals company Zoetis buys adivo from Pu... | U.S.-based veterinary drugmaker Zoetis has acquired Adivo, a biotech company developing therapeutic ... | bio-m.org/... |
| 20.12.2022 | adivo receives limited market authorization status from Euro... | adivo GmbH, a Martinsried-based company focussed on discovering species-specific therapeutic antibod... | bio-m.org/... |
| 18.10.2022 | adivo: EUR 2.5 million EU funding for therapies against infl... | Martinsried-based adivo GmbH has been awarded a €2.5 million European Innovation Council (EIC) Accel... | bio-m.org/... |
| 20.08.2018 | Pet Therapeutic Antibody Startup Adivo Closes Seed Financing | adivo, a German biotech company specializing in generating species-specific therapeutic antibodies f... | finsmes.co... |
| - | Pet therapeutic antibody firm adivo announces closure of see... | August 20, 2018 German biotech company adivo specializing in generating species-specific therapeuti... | htgf.de/en... |